Pulmatrix, Inc. announced the hiring of Dr. Margaret Wasilewski as the Company's Chief Medical Officer effective March 1st, 2022. Dr. Wasilewski leverages over 25 years of experience in pharmaceutical drug development. She led the clinical development program for treatment and recurrence prevention in Clostridioides difficile infection as Vice President Research and Development-Medical at Summit Therapeutics.

Dr. Wasilewski held various leadership roles at Eli Lilly and Company, Targanta Therapeutics, and Shire.